FR2206102B1 - - Google Patents

Info

Publication number
FR2206102B1
FR2206102B1 FR7340705A FR7340705A FR2206102B1 FR 2206102 B1 FR2206102 B1 FR 2206102B1 FR 7340705 A FR7340705 A FR 7340705A FR 7340705 A FR7340705 A FR 7340705A FR 2206102 B1 FR2206102 B1 FR 2206102B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7340705A
Other languages
French (fr)
Other versions
FR2206102A1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of FR2206102A1 publication Critical patent/FR2206102A1/fr
Application granted granted Critical
Publication of FR2206102B1 publication Critical patent/FR2206102B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7340705A 1972-11-15 1973-11-15 Expired FR2206102B1 (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US00306967A US3840546A (en) 1972-11-15 1972-11-15 Amino derivatives of pyrazolopyridine carboxamides
US48963674A 1974-07-18 1974-07-18
US05/583,373 US3966746A (en) 1972-11-15 1975-06-04 Amino derivatives of pyrazolopyridine carboxamides

Publications (2)

Publication Number Publication Date
FR2206102A1 FR2206102A1 (enExample) 1974-06-07
FR2206102B1 true FR2206102B1 (enExample) 1977-01-28

Family

ID=27405205

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7340705A Expired FR2206102B1 (enExample) 1972-11-15 1973-11-15

Country Status (5)

Country Link
US (2) US3840546A (enExample)
JP (1) JPS5714349B2 (enExample)
CA (1) CA1041504A (enExample)
FR (1) FR2206102B1 (enExample)
GB (1) GB1447672A (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003908A (en) * 1976-03-11 1977-01-18 E. R. Squibb & Sons, Inc. Derivatives of imidazo(4,5-b)pyridines
US4020072A (en) * 1976-05-04 1977-04-26 E. R. Squibb & Sons, Inc. 5-Aminomethyl-1H-pyrazolo[3,4-b]pyridines
US4088654A (en) * 1976-10-29 1978-05-09 E. R. Squibb & Sons, Inc. Derivatives of imidazo(4,5-b)pyridines
US4296239A (en) * 1977-06-08 1981-10-20 The Upjohn Company Amino-4H-s-triazolo[4,3-a][1,4]benzodiazepines
US4153796A (en) * 1978-07-10 1979-05-08 E. R. Squibb & Sons, Inc. Hydrazino derivatives of 1H-pyrazolo(3,4-b)-pyridine-5-carboxamides
JPS60191751U (ja) * 1984-05-30 1985-12-19 富士重工業株式会社 チエ−ンテンシヨナ
GB8425104D0 (en) * 1984-10-04 1984-11-07 Ici America Inc Amide derivatives
US5300498A (en) * 1993-06-04 1994-04-05 Hoechst-Roussel Pharmaceuticals Incorporated 6-piperazinyl-1H-pyrazolo[3,4-b]pyridine-3-carboxylic acids, esters, amides and related compounds
US6326379B1 (en) 1998-09-16 2001-12-04 Bristol-Myers Squibb Co. Fused pyridine inhibitors of cGMP phosphodiesterase
GB0230045D0 (en) 2002-12-23 2003-01-29 Glaxo Group Ltd Compounds
BR0314392A (pt) * 2002-09-16 2005-07-12 Glaxo Group Ltd Composto ou um sal do mesmo, composição farmacêutica, uso de um composto, método de tratamento e/ou profilaxia de uma doença inflamatória e/ou alérgica ou deficiência cognitiva em um mamìfero, e, combinação
CA2557004A1 (en) * 2003-12-19 2005-06-30 Glaxo Group Limited Pyrazolo [3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors
GB0405937D0 (en) * 2004-03-16 2004-04-21 Glaxo Group Ltd Compounds
WO2005090354A1 (en) * 2004-03-16 2005-09-29 Glaxo Group Limited PYRAZOLO[3,4-b] PYRIDINE COMPOUNDS, AND THEIR USE AS PDE4 INHIBITORS
UY31637A1 (es) * 2008-02-06 2009-08-03 Farmacoforos duales-antagonistas muscarinicos de pde4
CL2009000249A1 (es) * 2008-02-06 2009-09-11 Glaxo Group Ltd Compuestos derivados de pirazolo[3,4-b] piridin-butanodiamida; composicion farmaceutica; y su uso en el tratamiento del asma, enfermedad pulmonar obstructiva cronica, rinitis, dermatitis atopica, psoriasis.
AR070564A1 (es) * 2008-02-06 2010-04-21 Glaxo Group Ltd Derivados de 1h-pirazolo[3,4-b]piridin-5-ilo,inhibidores de fosfodiesterasas pde4 y antagonistas de receptores muscarinicos de acetilcolina(machr), utiles en el tratamiento y/o profilaxis de enfermedades respiratorias y alergicas,y composiciones farmaceuticas que los comprenden
US11505559B2 (en) 2017-10-30 2022-11-22 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Office Of Technology Transfer, National Institutes Of Health Substituted quinoline analogs as aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors
JP7677983B2 (ja) * 2020-01-23 2025-05-15 マイオフォルテ セラピューティクス，インク． Ｐｇｄｈ阻害剤、およびその作製と使用の方法
CN114907315B (zh) * 2022-05-17 2023-09-12 重庆医科大学 Selitrectinib中间体的合成方法
WO2025171341A2 (en) * 2024-02-08 2025-08-14 Aconcagua Bio, Inc. Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA711710B (en) * 1970-05-28 1971-12-29 Squibb & Sons Inc Amino derivatives of purazolo-pyridine carboxylic acids and esters
US3720675A (en) * 1970-08-10 1973-03-13 Squibb & Sons Inc Pyrazolo(3,4-b)pyridine-5-carboxamides
CA1003419A (en) * 1971-11-23 1977-01-11 Theodor Denzel Process for the production of pyrazolo (3,4-b) pyridines

Also Published As

Publication number Publication date
JPS5714349B2 (enExample) 1982-03-24
FR2206102A1 (enExample) 1974-06-07
JPS4980094A (enExample) 1974-08-02
US3840546A (en) 1974-10-08
CA1041504A (en) 1978-10-31
GB1447672A (en) 1976-08-25
US3966746A (en) 1976-06-29

Similar Documents

Publication Publication Date Title
FR2210465B3 (enExample)
JPS5714349B2 (enExample)
JPS4949445A (enExample)
CS156922B1 (enExample)
JPS5123756Y2 (enExample)
CS154487B1 (enExample)
CS153919B1 (enExample)
CS156987B1 (enExample)
CS156890B1 (enExample)
CS157307B1 (enExample)
CS151840B1 (enExample)
JPS4931912U (enExample)
JPS4921918U (enExample)
CS156136B1 (enExample)
CS156588B1 (enExample)
CS154024B1 (enExample)
CS156805B1 (enExample)
CH1117073A4 (enExample)
CH568120A5 (enExample)
CH566827A5 (enExample)
AU480295A (enExample)
CH563109A5 (enExample)
CH567161A5 (enExample)
CH575946A5 (enExample)
CH566403A5 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse